In the Guidelines for Physicians and Urologists "Watchful Waiting" for Benign Prostatic Hyperplasia (BPH) should be Replaced with Thermobalancing Therapy that Treats Prostate Effectively, Cost-Effectively and Safely

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2018, Vol 10, Issue 3

Abstract

Primary care physician is the first contact for screening for benign prostatic hyperplasia (BPH), conducting timely diagnostic work, and initiating relevant therapy. To protect men with lower urinary tract symptoms (LUTS) due to BPH from severe side effects and complications after standard BPH drugs and surgeries "watchful waiting” was introduced. Innovative Thermobalancing therapy with Dr Allen's therapeutic device, patented in the USA, has demonstrated the effectiveness of treatment of LUTS due to BPH by reducing the size of the enlarged prostate, urination symptoms and improving the quality of life. The results of 10-year follow-up and clinical trials confirm that there are no side effects after using Dr. Allen's device. Therefore, the guidelines for BPH treatment and management should be amended, and "watchful waiting” must be changed to Thermobalancing therapy. Benign prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms (LUTS) in aging men, worsening their quality of life, and physicians are positioned well to screen for BPH and to manage it [1]. Thus, primary care physician has an important role with the identification and early treatment of bothersome urinary symptoms caused by BPH [2]. It is important as the prevalence of LUTS/BPH increases with age, and the burden on the healthcare system and society may increase due to the ageing population [3]. BPH is a nonmalignant enlargement of the prostate, therefore it requires safe treatment to alleviate symptoms, delay disease progression, and lessen the chance of needing surgery for BPH. The results of 10-year follow-up and a clinical trial on Thermobalancing therapy (TT) with Dr Allen's therapeutic device (DATD) in 124 men with BPH have shown its effectiveness to treat urinary symptoms due to prostate enlargement. According to this clinical study, after use of DATD as mono-therapy the decrease in urine symptoms, measured by International Prostate Symptom Score, was accompanied by a significant decrease in the volume of the prostate gland, see Figure 1 [4]. It should be noted that the use of DATD improves of the quality of life (QoL) in observed men. In addition, DATD provides a new safe natural treatment method, patented is the USA [5].

Authors and Affiliations

Simon Allen

Keywords

Related Articles

Uric Acid in Heart Failure: Controversy Factor in The Multiple Pathogenesis of The Disease

The majority of individuals with traditional cardiovascular risk factors contributing in heart failure (HF) risk exhibited increased serum levels of uric acid. The role of SUA in HF manifestation appears to be controvers...

Ecosystem Services of Insects

Insects comprise the most diverse group of multicellular organisms in the planet Earth, which provide several ecosystem services like pollination, pest control (bio-control), decomposition, transference of energy through...

Challenges Facing Genetics and Materialism

There are under-appreciated, serious behavioral challenges to science’s under-standing of life and its DNA-basis. The general problem facing the DNA model, though, has been the inability to identify the DNA origins of ma...

Magnetism Study in Transition Metal Doped Superatoms: TMLi12(TM=Sc-Fe)

Through unbiased global optimization and density functional theory method, a series of stable icosahedral magnetic TMLi12 (TM=Sc-Fe) clusters are identified, where the 3d transition-metal element is embedded at the cente...

Five Posters Presentation on Safe and Clean Drinking Water, Environment, Work Place, Schools and Neighborhood Programs

The Idea is to Present and Collect Number of Five Posters on the following Topics men-tioned below in one Article to be Prepared and published for Research Purposes: All the Posters (Poster 1-Poster 5) wer...

Download PDF file
  • EP ID EP588400
  • DOI 10.26717/BJSTR.2018.10.001968
  • Views 139
  • Downloads 0

How To Cite

Simon Allen (2018). In the Guidelines for Physicians and Urologists "Watchful Waiting" for Benign Prostatic Hyperplasia (BPH) should be Replaced with Thermobalancing Therapy that Treats Prostate Effectively, Cost-Effectively and Safely. Biomedical Journal of Scientific & Technical Research (BJSTR), 10(3), 7876-7878. https://europub.co.uk/articles/-A-588400